AU1933800A - Compositions and methods for regulating bacterial pathogenesis - Google Patents

Compositions and methods for regulating bacterial pathogenesis Download PDF

Info

Publication number
AU1933800A
AU1933800A AU19338/00A AU1933800A AU1933800A AU 1933800 A AU1933800 A AU 1933800A AU 19338/00 A AU19338/00 A AU 19338/00A AU 1933800 A AU1933800 A AU 1933800A AU 1933800 A AU1933800 A AU 1933800A
Authority
AU
Australia
Prior art keywords
autoinducer
harveyi
typhimurium
seq
alteration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19338/00A
Other languages
English (en)
Inventor
Bonnie Bassler
Michael G. Surette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Technologies International Inc
Princeton University
Original Assignee
Technologies International Inc, University of
University Technologies International Inc
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technologies International Inc, University of, University Technologies International Inc, Princeton University filed Critical Technologies International Inc, University of
Publication of AU1933800A publication Critical patent/AU1933800A/en
Assigned to PRINCETON UNIVERSITY, UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. reassignment PRINCETON UNIVERSITY Amend patent request/document other than specification (104) Assignors: PRINCETON UNIVERSITY
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU19338/00A 1998-12-02 1999-12-02 Compositions and methods for regulating bacterial pathogenesis Abandoned AU1933800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11057098P 1998-12-02 1998-12-02
US60110570 1998-12-02
PCT/US1999/028751 WO2000032152A2 (fr) 1998-12-02 1999-12-02 Compositions et methodes de regulation de la pathogenese bacterienne

Publications (1)

Publication Number Publication Date
AU1933800A true AU1933800A (en) 2000-06-19

Family

ID=22333745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19338/00A Abandoned AU1933800A (en) 1998-12-02 1999-12-02 Compositions and methods for regulating bacterial pathogenesis

Country Status (6)

Country Link
EP (1) EP1135144A4 (fr)
JP (1) JP2003526327A (fr)
KR (1) KR20010093800A (fr)
AU (1) AU1933800A (fr)
CA (1) CA2351731A1 (fr)
WO (1) WO2000032152A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326542B2 (en) * 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
AU2001259734A1 (en) 2000-05-10 2001-11-20 Princeton University Compounds and methods for regulating bacterial growth and pathogenesis
US6416785B1 (en) 2000-08-23 2002-07-09 Biolitec Ag Molecular probes for targeting of cell density-indicating compounds
WO2002088298A1 (fr) * 2001-04-27 2002-11-07 The Procter & Gamble Company Composes, compositions et procedes permettant de reguler des films biologiques
CA2443287A1 (fr) * 2001-05-21 2002-11-28 Quorex Pharmaceuticals, Inc. Methodes de regulation des bacteries
CA2455504A1 (fr) * 2001-08-24 2003-03-06 Quorex Pharmaceuticals, Inc. Agents antibacteriens bases sur une liaison toxoanion
US7208612B2 (en) 2001-08-24 2007-04-24 Princeton University Crystals of LuxP and complexes thereof
WO2005072274A2 (fr) * 2004-01-23 2005-08-11 The Trustees Of Princeton University Composes autoinducteurs-2 utilises comme agents immunomodulateurs
US20060229259A1 (en) 2004-04-12 2006-10-12 Miller Stephen T AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
US7405050B2 (en) 2004-04-12 2008-07-29 The Trustees Of Princeton University Small RNAs and bacterial strains involved in quorum sensing
ATE470499T1 (de) 2004-09-01 2010-06-15 Hatch Ltd Verbundeinblasrohr
GB0620715D0 (en) 2006-10-18 2006-11-29 Univ Durham Ethanol production
US8846327B2 (en) 2007-10-17 2014-09-30 Kao Corporation Method of quantifying autoinducer-2
KR101222907B1 (ko) 2010-09-08 2013-01-16 고려대학교 산학협력단 여시니아 엔테로콜리티카 랜덤 지노믹 ｄｎａ 단편을 이용한 유전자 칩
CN106434843A (zh) * 2016-10-27 2017-02-22 江南大学 一种选择性分离培养b群链球菌的培养基及其制备方法
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
AU2021224588B2 (en) 2020-02-18 2024-07-18 Gilead Sciences, Inc. Antiviral compounds
EP4323362B1 (fr) 2021-04-16 2025-05-07 Gilead Sciences, Inc. Procédés de préparation de carbanucléosides à l'aide d'amides
AU2022328698B2 (en) 2021-08-18 2025-02-20 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
CN115820605A (zh) * 2022-10-12 2023-03-21 河南师范大学 一种体外合成群体感应信号分子ai-2的方法
CN117305155B (zh) * 2023-08-28 2024-07-05 江苏省家禽科学研究所 一种抑制沙门氏菌毒力因子的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108307D0 (en) * 1991-04-18 1991-06-05 Univ Nottingham Autoinducer
AU2422792A (en) * 1991-07-30 1993-03-02 Bio-Technical Resources Device for detecting aqueous contaminants
FI96697C (fi) * 1993-08-18 2001-05-16 Valio Oy Uudet Streptococcus thermophilus -kannat ja niiden käyttö antibioottie n määrittämiseen

Also Published As

Publication number Publication date
WO2000032152A3 (fr) 2002-12-12
JP2003526327A (ja) 2003-09-09
CA2351731A1 (fr) 2000-06-08
KR20010093800A (ko) 2001-10-29
EP1135144A4 (fr) 2005-07-20
EP1135144A1 (fr) 2001-09-26
WO2000032152A2 (fr) 2000-06-08

Similar Documents

Publication Publication Date Title
US6844423B2 (en) Compositions and methods for regulating bacterial pathogenesis
US7666619B2 (en) Compounds and methods for regulating bacterial growth and pathogenesis
AU1933800A (en) Compositions and methods for regulating bacterial pathogenesis
US7326542B2 (en) Compositions and methods for regulating bacterial pathogenesis
Rottner et al. Bacteria-host-cell interactions at the plasma membrane: stories on actin cytoskeleton subversion
Milton et al. Quorum sensing in Vibrio anguillarum: characterization of the vanI/vanR locus and identification of the autoinducer N-(3-oxodecanoyl)-L-homoserine lactone
US7427408B2 (en) Quorum sensing and biofilm formation
US7183099B2 (en) Inhibitors of autoinducer transporters
Li et al. The GntR-like transcriptional regulator HutC involved in motility, biofilm-forming ability, and virulence in Vibrio parahaemolyticus
Zhang et al. ArnB mediates CAMP resistance and in vivo colonization in the fish pathogen Edwardsiella piscicida
JP4932731B2 (ja) シグナルペプチド、核酸分子及び治療方法
US20070141578A1 (en) LuxO-sigma54 interactions and methods of use
MXPA01005448A (en) Compositions and methods for regulating bacterial pathogenesis
Shumard et al. Regulation of toxin A synthesis in Pseudomonas aeruginosa
KR20220151425A (ko) 병원성 비브리오균에 대한 병원성 억제제의 스크리닝 방법 및 그에 의해 스크리닝된 비브리오균 병원성 억제제
Hoffman The Role of the Transcriptional Antiterminator RfaH in Lipopolysaccharide Synthesis, Resistance to Antimicrobial Peptides, and Virulence of Yersinia Pseudotuberculosis and Yersinia Pestis
SHUMARD et al. Regulation of Toxin A Synthesis in Pseudomonas
Anderton DNA array analysis to detect gene expression changes in Borrelia burgdorferi after treatment with a bactericidal antibody

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: PRINCETON UNIVERSITY, UNIVERSITY TECHNOLOGIES INTE

Free format text: FORMER NAME: PRINCETON UNIVERSITY

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20010605

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted